The novel VEGF receptor 2 inhibitor YLL545 inhibits angiogenesis and growth in breast cancer

Jianbo Zhang(Chongqing Medical University), Rong Xiang(Scripps Research Institute)
Oncotarget
May 17, 2016
Cited by 19


Related Papers